• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Exisulind
Date Designated:  02/14/1994
Orphan Designation:  For the suppression and control of colonic adenomatous polyps in the inherited disease adenomatous polyposis coli.
Orphan Designation Status:  Designated
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
OSI Pharmaceuticals, Inc.
41 Pinelawn Road
Melville, New York 11747
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.